Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing



Status:Recruiting
Conditions:Cancer, Cancer, Other Indications
Therapuetic Areas:Oncology, Other
Healthy:No
Age Range:18 - Any
Updated:1/24/2018
Start Date:October 1, 2017
End Date:January 30, 2022
Contact:Ana-Maria Vranceanu, PhD
Email:avranceanu@mgh.harvard.edu
Phone:6176437996

Use our guide to learn which trials are right for you!

The aims of this study are to compare the effect and durability of two stress and symptom
management programs tailored for patients with neurofibromatosis on quality of life and
psychosocial functioning.

The aims of this study are to compare the effect of two stress and symptom management
programs tailored for patients with neurofibromatosis on quality of life and psychosocial
functioning. We will also examine the degree to which treatment-dependent improvements in
quality of life are mediated by improvements in depression, anxiety, distress, mindfulness,
gratitude, social support, empathy, optimism, coping, pain intensity and pain interference.

Inclusion Criteria:

- Has a diagnosis of NF1, NF2, or Schwannomatosis

- 18 years of age or older

- Is capable of completing and fully understanding the informed consent process, study
procedures, and study assessments in English

- At least 6th grade self-reported reading level

- Self-reported difficulties coping with stress and NF-symptoms

- Score of 6 or higher on Perceived Stress Scale 4-Item (PSS-4)

Exclusion Criteria:

- Has major medical comorbidity not NF related expected to worsen in the next 12 months

- Recent (within past 3 months) change in antidepressant medication

- Recent (within past 3 months) participation in cognitive behavioral therapy or
relaxation therapy

- Has significant mental health diagnosis requiring immediate treatment (e.g., bipolar
disorder, psychotic disorder, active substance use dependence)

- Unable or unwilling to complete assessments electronically via REDCap

- Unable or unwilling to participate in group videoconferencing sessions
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
Phone: 617-643-7996
?
mi
from
Boston, MA
Click here to add this to my saved trials